FDA-cleared profile

BriefCase

Aidoc Medical, Ltd. · X-ray/Radiography · FDA-cleared (510(k))

Authorized purpose: BriefCase analyzes frontal chest X-rays in adults or transitional adolescents at least 18 years old to triage suspected vertically malpositioned endotracheal tubes relative to the carina; it flags tip positions more than 5 cm above, less than 2 cm above, or below the carina and requires standard-of-care image review.

Clinical role
Frontal CXR triage and notification for suspected vertical ETT malposition
Images and patients
X-ray/Radiography · Chest/Lung
Key limitation
Keep in mind: The device assesses only vertical ETT-tip position relative to the carina, does not factor patient positioning, cannot detect esophageal intubation, provides no result when the carina is not well visualized, and may falsely alert on a properly positioned double-lumen ETT; the notification is informational and not diagnostic.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: BriefCase analyzes frontal chest X-rays in adults or transitional adolescents at least 18 years old to triage suspected vertically malpositioned endotracheal tubes relative to the carina; it flags tip positions more than 5 cm above, less than 2 cm above, or below the carina and requires standard-of-care image review.
  • Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Chest/Lung Input: Frontal chest X-ray in DICOM 3.0 from compatible X-ray scanners; the carina must be well visualized for a result.
  • Who uses it?Intended users: Appropriately trained medical specialists in hospital networks; the notification supports triage while full-image review and professional judgment remain required.
  • What does the software produce?Output: Desktop triage notification for suspected vertical ETT malposition with a compressed, unannotated grayscale preview labeled not for diagnostic use; the original image remains unchanged.
  • What is its most important limitation?Key limitation: The device assesses only vertical ETT-tip position relative to the carina, does not factor patient positioning, cannot detect esophageal intubation, provides no result when the carina is not well visualized, and may falsely alert on a properly positioned double-lumen ETT; the notification is informational and not diagnostic.

Clinical takeaway. Clinical role: BriefCase analyzes frontal chest X-rays in adults or transitional adolescents at least 18 years old to triage suspected vertically malpositioned endotracheal tubes relative to the carina; it flags tip positions more than 5 cm above, less than 2 cm above, or below the carina and requires standard-of-care image review.

Evidence takeaway. Evidence from the reviewed source record: A retrospective, blinded, multicenter pivotal study evaluated 921 cases from 5 US clinical sites against a 2-of-3 majority reference of senior board-certified radiologists. Sensitivity was 86.81% and specificity 92.02%; BriefCase time-to-notification was 4.93 minutes in 182 true-positive cases.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
BriefCase analyzes frontal chest X-rays in adults or transitional adolescents at least 18 years old to triage suspected vertically malpositioned endotracheal tubes relative to the carina; it flags tip positions more than 5 cm above, less than 2 cm above, or below the carina and requires standard-of-care image review.
  • Exact FDA submission
  • Checked 2026-09-07
Workflow role
Frontal CXR triage and notification for suspected vertical ETT malposition
  • Exact FDA submission
  • Checked 2026-09-07
Required input
Frontal chest X-ray in DICOM 3.0 from compatible X-ray scanners; the carina must be well visualized for a result.
  • Exact FDA submission
  • Checked 2026-09-07
Output and clinician action
Desktop triage notification for suspected vertical ETT malposition with a compressed, unannotated grayscale preview labeled not for diagnostic use; the original image remains unchanged.
  • Exact FDA submission
  • Checked 2026-09-07
Care setting
Hospital networks and acute radiology workflows for adults and transitional adolescents aged 18 years and older.
  • Exact FDA submission
  • Checked 2026-09-07
Intended users
Appropriately trained medical specialists in hospital networks; the notification supports triage while full-image review and professional judgment remain required.
  • Exact FDA submission
  • Checked 2026-09-07
Limitations
The device assesses only vertical ETT-tip position relative to the carina, does not factor patient positioning, cannot detect esophageal intubation, provides no result when the carina is not well visualized, and may falsely alert on a properly positioned double-lumen ETT; the notification is informational and not diagnostic.
  • Exact FDA submission
  • Checked 2026-09-07
Evidence summary
A retrospective, blinded, multicenter pivotal study evaluated 921 cases from 5 US clinical sites against a 2-of-3 majority reference of senior board-certified radiologists. Sensitivity was 86.81% and specificity 92.02%; BriefCase time-to-notification was 4.93 minutes in 182 true-positive cases.
  • Exact FDA submission
  • Checked 2026-09-07

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
A retrospective, blinded, multicenter pivotal study evaluated 921 cases from 5 US clinical sites against a 2-of-3 majority reference of senior board-certified radiologists. Sensitivity was 86.81% and specificity 92.02%; BriefCase time-to-notification was 4.93 minutes in 182 true-positive cases.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-07
Reported sensitivity
86.81% (95% CI 81.02%-91.36%)
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-07
Reported specificity
92.02% (95% CI 89.20%-93.87%)
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-07

Sensitivity for vertically malpositioned ETT triage

86.81 percent

  • EndpointDetection sensitivity against 2-of-3 majority radiologist reference
  • Population921 frontal chest X-ray cases from 5 US clinical sites
  • Tested versionBriefCase vertically malpositioned ETT triage submitted in K221330; build not stated

Specificity for vertically malpositioned ETT triage

92.02 percent

  • EndpointExclusion specificity against 2-of-3 majority radiologist reference
  • Population921 frontal chest X-ray cases from 5 US clinical sites
  • Tested versionBriefCase vertically malpositioned ETT triage submitted in K221330; build not stated

BriefCase time-to-notification

4.93 minutes

  • EndpointDICOM receipt, de-identification, cloud upload, analysis, and notification for a true-positive suspect case
  • Population182 true-positive cases in the five-center study
  • Tested versionBriefCase vertically malpositioned ETT triage submitted in K221330; build not stated

BriefCase vertically malpositioned ETT pivotal validation

  • DesignRetrospective blinded multicenter validation against a 2-of-3 majority senior board-certified radiologist reference
  • Population921 frontal chest X-ray cases from 5 US clinical sites; time-to-notification analysis included 182 true-positive cases.
  • Scopeexact submission
  • Tested versionBriefCase vertically malpositioned ETT triage submitted in K221330; build not stated
  • Samplen=921
  • Sites5
  • IndependenceIndependence not established

K221330

The FDA states that pivotal cases were distinct in time or center from training cases. That establishes dataset separation, not independent investigators or sponsorship.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-04

No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Frontal chest X-ray in DICOM 3.0 from compatible X-ray scanners; the carina must be well visualized for a result.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-07 · FDA 510(k) K221330: BriefCase malpositioned endotracheal tube triage

  2. Routing

    Source context, not route validation: The exact system comprises Aidoc Hospital Server/Orchestrator for image acquisition, Aidoc Cloud Server for processing, and Aidoc Desktop Application for workflow integration. DICOM images are received, filtered, and de-identified before processing, with notifications sent to the desktop application and shared PACS workflows supported.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-07 · FDA 510(k) K221330: BriefCase malpositioned endotracheal tube triage

  3. AI processing

    Source context, not route validation: The exact FDA package describes BriefCase as three modules: an Aidoc Hospital Server (AHS/Orchestrator) for image acquisition, an Aidoc Cloud Server for image processing, and an Aidoc Desktop Application, with DICOM exams de-identified and uploaded to the cloud for analysis. Current hosting, data flow, and commercial configuration require vendor confirmation.

    Scope: Exact FDA submission. Packet wording: "The device consists of the following three modules: (1) Aidoc Hospital Server (AHS/Orchestrator) for image acquisition; (2) Aidoc Cloud Server (ACS) for image processing; and (3) Aidoc Desktop Application for workflow integration." … "The BriefCase time-to-notification includes the time to get the DICOM exam, de-identify it, upload it to the cloud, analyze and send a notification on a positive suspect case back to the desktop application.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-11-14 · FDA 510(k) K221330: BriefCase malpositioned endotracheal tube triage

  4. Returned objects

    Source context, not route validation: Desktop triage notification for suspected vertical ETT malposition with a compressed, unannotated grayscale preview labeled not for diagnostic use; the original image remains unchanged.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-07 · FDA 510(k) K221330: BriefCase malpositioned endotracheal tube triage

  5. Viewer/worklist/report

    Unresolved route: Desktop triage notification for suspected vertical ETT malposition with a compressed, unannotated grayscale preview labeled not for diagnostic use; the original image remains unchanged.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-07 · FDA 510(k) K221330: BriefCase malpositioned endotracheal tube triage

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The exact FDA package describes BriefCase as three modules: an Aidoc Hospital Server (AHS/Orchestrator) for image acquisition, an Aidoc Cloud Server for image processing, and an Aidoc Desktop Application, with DICOM exams de-identified and uploaded to the cloud for analysis. Current hosting, data flow, and commercial configuration require vendor confirmation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "The device consists of the following three modules: (1) Aidoc Hospital Server (AHS/Orchestrator) for image acquisition; (2) Aidoc Cloud Server (ACS) for image processing; and (3) Aidoc Desktop Application for workflow integration." … "The BriefCase time-to-notification includes the time to get the DICOM exam, de-identify it, upload it to the cloud, analyze and send a notification on a positive suspect case back to the desktop application.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

Integration
The exact system comprises Aidoc Hospital Server/Orchestrator for image acquisition, Aidoc Cloud Server for processing, and Aidoc Desktop Application for workflow integration. DICOM images are received, filtered, and de-identified before processing, with notifications sent to the desktop application and shared PACS workflows supported.
  • Exact FDA submission
  • Checked 2026-09-07
Security
Aidoc's current public Security & Privacy page says its security work is led by a CISO and security team, that it has adopted the NIST Cybersecurity Framework, and that its platform runs on AWS and Azure using EDR, encryption, SIEM and CSPM tooling. The page's list of standards and certifications did not load as readable text, so no certification is stated here.
  • Vendor-wide
  • Checked 2026-10-25

Vendor-wide marketing statement, not an independent attestation. It does not establish certificate scope or expiry, the controls of this exact release, data location, retention, identity and access, or incident-response terms for a deployed configuration. Obtain these from the vendor.

Monitoring
Aidoc's security page states that its platform runs on AWS and Azure and that customer data protection is achieved with the use of EDR, encryption, SIEM, CSPM and other technologies.
  • Vendor-wide
  • Checked 2026-10-27

Vendor statement, not an attestation. The page names Aidoc's platform generally and does not scope these capabilities to any specific product release; exact-release scope is not established. The page lists technology categories in use; it states no uptime, alerting or response-time SLAs.

DICOM/PACS/cloud triage workflow

The exact submission describes DICOM 3.0-compatible X-ray scanners, PACS and radiology workstations, Aidoc Hospital Server acquisition, Aidoc Cloud Server processing, and Aidoc Desktop workflow integration with filtered/de-identified image handling.

exact submission · checked 2026-09-07

Current Aidoc radiology workflow context

Aidoc's current official radiology page lists ETT malposition among radiology solutions and describes a Widget interface with key images/summary, workstation access, PACS worklist integration, and care-team communication; current family capabilities are not assumed to prove the exact K221330 build.

product family · checked 2026-09-07

Current family workflow context only; exact-version compatibility requires confirmation.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K221330
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
X-ray/Radiography
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-07
Anatomy
Chest/Lung
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-07
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2022-11-18
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-07Last searched
26Fields reviewed
10Source classes checked
20Screened PubMed leads
6Screened trial leads
0Unreviewed FDA recall leads

The stored PubMed, ClinicalTrials.gov, and exact-submission recall metadata candidates were screened by identifier and count. The records were not treated as a full paper, trial, or postmarket review. The current discovery snapshot contains 20 PubMed and 6 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, literature index, trial registry, fda device recall, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-07 - Exact FDA submission

    No public amount, range, currency, geography, or contract term was established.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission

    Bounded web search on 2026-10-26 (query: "Aidoc BriefCase reimbursement NTAP CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. Aidoc's 2026-08-13 release announces a Medicare NTAP for CARE Body CT Multi-Triage; it does not name this product or clearance. This records what was found, not that none exists; eligibility depends on payer, site of service and use case.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-07 - Exact FDA submission

    Training, credentialing, and implementation support terms were not established.

8 sources - 3 history items

Source ledger

  1. FDA 510(k) K221330: BriefCase malpositioned endotracheal tube triage

    U.S. Food and Drug Administration - Published 2022-11-18 - Accessed 2026-09-07

    Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation, deployment

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. BriefCase-Malpositioned Endotracheal Tube Triage model card (K221330)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: purpose, modality, intendedUsers, careSetting, output, limitations, reportedSensitivity, reportedSpecificity, evidenceSummary, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. Aidoc radiology solutions

    Aidoc - Accessed 2026-09-08

    Scope: productFamily, clinicalWorkflow, PACS, implementationCapabilities

  8. Aidoc Security & Privacy

    Aidoc Medical - Accessed 2026-10-25

    Scope: security

Research history

  1. K221330 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K243808

Rayvolve PTX-PE

AZmed

Authorized purpose: Passive study-level worklist triage for suspected pneumothorax and/or pleural effusion on adult PA or AP chest X-rays; it is not a proactive specialist alert.

Modality
X-ray/Radiography
Anatomy
Chest/Lung
Decision
2025-03-21
FDA-cleared K232410

SmartChest

Milvue

Authorized purpose: Passive worklist prioritization for suspected pleural effusion and/or pneumothorax on frontal PA or AP chest radiographs in transitional adolescents aged 18-21 and adults aged 22 years and older; not diagnostic or a rule-out function.

Modality
X-ray/Radiography
Anatomy
Chest/lung
Decision
2024-05-10

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history